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Abstract
In the first few hours following Newcastle disease viral infection of human monocyte-derived dendritic cells, the induction of
IFNB1 is extremely low and the secreted type I interferon response is below the limits of ELISA assay. However, many
interferon-induced genes are activated at this time, for example DDX58 (RIGI), which in response to viral RNA induces IFNB1.
We investigated whether the early induction of IFNBI in only a small percentage of infected cells leads to low level IFN
secretion that then induces IFN-responsive genes in all cells. We developed an agent-based mathematical model to explore
the IFNBI and DDX58 temporal dynamics. Simulations showed that a small number of early responder cells provide a
mechanism for efficient and controlled activation of the DDX58-IFNBI positive feedback loop. The model predicted
distributions of single cell responses that were confirmed by single cell mRNA measurements. The results suggest that large
cell-to-cell variation plays an important role in the early innate immune response, and that the variability is essential for the
efficient activation of the IFNB1 based feedback loop.
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Introduction
The innate immune response to viral infection is essential in
fighting infections, and the dynamics of the response can
determine whether the infection evolves into pathology [1].
Dendritic cells (DCs) are the primary response cells mediating
the progression from innate to adaptive immunity and the
induction of self-tolerance [2,3]. It has recently been recognized
that understanding the internal dynamics of DCs following viral
infection can help elucidate the function of the immune system
and help lead to better vaccination protocols [4,5,6,7]. Many
viruses have evolved immune antagonists that subvert the innate
immune response and facilitate their replication. Newcastle disease
virus (NDV), however, is an avian virus that lacks a functioning
immune antagonist for human cells [7,8,9]. Therefore it efficiently
stimulates the innate immune response and represents an ideal
stimulus with which to probe the activation dynamics of human
DCs.
Upon viral infection of DCs, constitutive RIG-I proteins (coded
from the gene DDX58) can be activated upon detecting evidence of
negative stranded viruses such as NDV in the cytoplasm, leading
to IFNB1 induction through a signaling cascade. IFNB1 encodes
IFNb, which is a type 1 interferon (IFN) that is secreted into the
extracellular medium, where it binds to IFN cell surface receptors
on the secreting cell and on neighboring cells. This binding
activates a gene program that plays an essential role in both the
DC antiviral response [10] and in DC maturation [9,11], and
causes the up-regulation of many genes [12]. In particular, IFNb
binding activates the Jak/Stat pathway, inducing the DDX58 gene
and leads to RIG-I production. In infected cells, the activation of
newly induced RIG-I, as well as of other genes involved in
interferon induction such as IRF7 [13], leads to additional IFNB1
production, thus completing an IFNB1-DDX58 positive feedback
loop.
Previous single cell measurements of IFNB1 induction in NDV
infected human monocyte-derived dendritic cells (MDDCs)
showed large cell-to-cell variation ranging over 3–4 orders of
magnitude at 8–10 hours after infection. These results, comple-
mented by simultaneous measurements of DDX58 (coding for
RIG-I) production at 6 and 10 hours, are confirmed by the
experiments presented here. Taking as a starting point the
observed stochasticity of the cellular IFNB1 response, we
developed a stochastic agent-based model (ABM) that, after a fit
to the later time data points, allowed extrapolation to early times
after infection, where direct measurements are very difficult due to
sampling limitations. Model simulations suggest that there is a
small subset of early responder cells responsible for propagating
cellular resistance to viral infection through the efficient activation
of the IFNB1-DDX58 feedback loop. The existence of such a subset
resolves an apparent paradox of average cellular response, namely
the fact that contrary to the temporal order of the feedback loop,
IFNB1 production remains near the limit of detection until 6 hours
after infection, whereas that of DDX58, induced by IFNb through
the feedback loop, reaches a significant level of expression several
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average cell responses can obscure the actual single cell response
dynamics and support the role of cell-to-cell response variability in
maintaining an efficient and controlled immune response.
Results
The population (average) levels of IFNB1 and DDX58
transcripts in human MDDCs were measured as a function of
time following NDV infection at multiplicity of infection,
MOI=0.5, as shown in Figure 1 (see also Supplementary
Figure S1). Our previous work [14] showed that at ten hours post
infection both genes have reached approximately maximal
expression levels. Half-maximal DDX58 expression occurred
approximately 3 hours after infection, while half-maximal IFNB1
expression occurred 4–5 hours later. The time course for synthesis
of the NDV L gene at 0, 3, 6, and 10 hours post infection
(Supplementary Figure S1C) showed significant NDV genome
replication well before the half-maximal expression level of IFNB1
was reached. MXA induction (Supplementary Figure S1D)
mimicked that of DDX58 (Supplementary Figure S1B), and
IFNA1 induction (Supplementary Figure S1E) mimicked that of
IFNB1 (Supplementary Figure S1A), as expected from their
common activation pathways. However, since DDX58 is an
interferon-induced gene, we would expect its expression to
increase only after IFNB1 expression increases.
Paradoxically, the reverse temporal order is observed
(Figure 1A and Supplementary Figure S1). However, close
inspection of the data (Supplementary Figure S2A) shows
evidence for an initial and small first phase of IFNB1 induction
that begins as early as 1 hour after infection and never reaches
levels above 1% of maximum until the sizeable induction observed
after 6 hours. To evaluate the robustness of this low level IFNB1
induction, we performed similar experiments with MOI=0.1, 0.5,
1.0, 2.0 and 5.0 (Supplementary Figure S2), and obtained similar
results. These findings demonstrate that an early low level of
induction of IFNB1 precedes - and therefore might be responsible
for - the induction of DDX58.
The role of this early IFNb in the induction of DDX58 was
tested by performing population and single cell assays measuring
IFNB1 and DDX58 in the presence and absence of antibodies that
attenuate extracellular interferon signaling. Cells were infected at
an MOI=0.5. As shown in Figure 2A, a mixture of antibodies
binding interferons and the interferon receptor eliminated the
induction of DDX58 and dramatically reduced induction of
IFNB1, confirming the formulation that IFNb produced from
the nearly undetectable levels of early IFNB1 is responsible for the
apparently paradoxical induction of DDX58.
As only half the cells were infected, in order to determine the
distribution of responses observed in individual cells, we
performed single cell mRNA assays (Figure 2B). Notably, in
the absence of blocking antibodies about half the cells showed
induction of IFNB1, while all cells showed induction of DDX58. In
the presence of blocking antibodies, most cells showed control
levels of both transcripts. Because IFNB1 is an intronless gene, the
control levels of expression reflect the 4 DNA strands encoding the
gene within each cell (the sense and the anti-sense DNA strands of
the gene on both alleles). In the presence of blocking antibodies, a
few cells were detected that showed a modest induction of INFB1
or of DDX58 greater than the levels measured in control cells.
The results shown in Figure 2B showed significant cell-to-cell
variability in the expression level of IFNB1, which ranged over
three orders of magnitude. One factor that can differ among cells
is their degree of differentiation, which is reflected in the level of
the differentiation marker CD14. In order to test whether this
variability contributes the large variation in gene induction with
virus infection, we sorted cells into high and low CD14
subpopulations prior to infection with virus. In both groups, a
similar and broad distribution of single-cell IFNB1 gene responses
was observed (Supplementary Figure S3). These results suggest
that the heterogeneous levels of IFNB1 in individual cells does not
result from cell heterogeneity in differentiation and reflects both
the absence of expression in uninfected cells and the noise in the
transcriptional induction of this gene.
What is the source of the low level of IFNB1 detected at early
time points after virus infection that is necessary to initiate the
positive feedback loop and generate a full antiviral response?
Given the high intercellular variation in responses, the most
parsimonious hypothesis is that a few infected cells are competent
to induce IFNB1 before interferon activation of JAK-STAT
signaling. We explored this hypothesis and its implications by
developing a formal model of the system that could lead to testable
predictions.
The model was agent-based (ABM) stochastically simulating
intercellular IFNb signaling and the temporal evolution of the
immune response in individual cells. The constitutive RIG-I
distribution across cells, and the parameters of IFNB1 induction
were taken such that only the small number of cells with large
amounts of RIG-I protein responded to infection. (see Materials
and Methods and for additional details). The model can be
accessed at http://tsb.mssm.edu/DCresponse2viralInfABM.
Figure 3A shows the time courses of the average induction of
IFNB1 and of DDX58 obtained in the simulation, which are
consonant with the experimental results shown in Figure 1A.A
more stringent test of the model is provided by the distributions of
single cell results obtained by simulation (Figure 3B). The model
was simulated using a constant parameter set both with and
without blocking antibodies and the pattern of responses in single
cells was determined. The antibody blockage was implemented in
the model by introducing a degradation rate for extracellular
interferon b protein, which allowed it time to bind to the cell that
secreted it, but made it unlikely that it would reach a neighboring
Figure 1. Time course of IFNB1 and DDX58 induction. Measure-
ment of IFNB1 (solid line) and DDX58 (dashed line) expression in human
DCs at 1, 2, 4, 6, 8, 10, 12, 14, 16, and 18 hours following NDV infection.
Percent of maximal induction was measured by microarray, compared
to non-infected control, and shows that half-maximal induction of
DDX58 occurs hours prior to IFNB1 half-maximal induction.
doi:10.1371/journal.pone.0016614.g001
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receptor binding rate. Uninfected cells can be roughly character-
ized as those with less than ten copies of IFNB1. The RIG-I
mRNA distribution in uninfected cells was considerably shifted
downward when antibodies blocked the paracrine loop
(Figure 3B), as the paracrine loop acts as an inducer of RIG-I.
Furthermore, DDX58 and IFNB1 showed significant correlation
within individual cells at 11 hours, as expected when each cell is
activated only by autocrine signaling.
In order to test the distributions predicted by these simulations,
experiments were performed using single cell assays that simulta-
neously measured both IFNB1 and DDX58. The single cell data
presented in Figure 2B did not include measurement of both
transcripts within each individual cell and could not determine
whether the small number of cells showing increased IFNB1 and
DDX58 levels in the presence of blocking antibodies were the same
subset of cells. As had been seen in the simulations, the
experimentally obtained co-expression measurements in the
presence of blocking antibodies showed a significant correlation
between IFNB1 and DDX58 (Figure 4). Moreover, in the presence
of antibodies the level of RIG-I expression in cells drops overall
(Figure4),ascanalsobeseeninthesimulationresults(Figure3B).
The interpretation of these experimental results that use antibodies
to block interferon signaling is that while the paracrine signaling
appears to be efficiently cancelled, the autocrine loop is leaky,
leading to the observed correlation and higher copy numbers of
IFNB1 at 11 hours. The persistence of control levels of DDX58 and
of IFNB1 in some, presumably uninfected, cells at 11 hours when
antibodies were present also confirmed the effectiveness of the
blockade of paracrine signaling. Overall, the experimental results
are in agreement with the salient features about single cell response
distribution in the absence and presence of blocking antibodies that
were predicted by the model simulations.
This consistency between model and experiment at later times
provides some assurance in using simulations to investigate the
distribution of responses at early time points. The results of such
simulations (Figure 5) support the hypothesis that the initiation of
the positive feedback loop results from a very small number of cells
that are activated and release interferon at early time-points. This
is made clear in Figure 6, where we plot the number of bound
receptors (which is connected to the rate of DDX58 induction)
versus the IFNB1 copy number for specific cells at different times
through the simulation. In the resulting trajectories each point
represents the simulation result at time points separated by 10
minutes. Cellular responses fall into typical patterns for uninfected,
infected early responder and infected late responder cells. For
uninfected cells (Figure 6A) there is no IFNB1 induction despite
increasing receptor binding. For early responder cells (Figure 6C)
Figure 2. DDX58 and IFNB1 mRNA expression level. 2A. Total mRNA copy number. DDX58 and IFNB1 mRNA were measured by quantitative real-
time PCR and the relative IFNB1 and DDX58 expression levels were normalized to ACTB. The columns show the gene expression level 7 hrs post
treatment [NDV only (NDV), NDV plus blocking antibodies (NDV+Abs), not infected (ni), not infected with blocking antibodies (ni+Abs)]. Left panel:
IFNB1. Right panel: DDX58. Error bars represent measurement error. 2B. Single cell mRNA expression. DDX58 and IFNB1 mRNA in individual DCs were
measured 7 hrs post treatment by the hemi-nested PCR protocol illustrated in Supplementary Figure S4. The copy numbers of both DDX58 and
IFNB1 in single DCs (normalized to ACTB) were determined for all cells with detectable expression of the mRNAs. Each symbol shows the gene
expression in a single cell. The treatments were same as those in Figure 2A, but with uninfected DCs labeled as control (Ctr). Left panel: IFNB1. Right
panel: DDX58.
doi:10.1371/journal.pone.0016614.g002
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bound receptors and IFNB1 through early autocrine and later
paracrine signaling. For late responder cells (Figure 6B) the
behavior at early times is opposite to that of early responders with
infinite slope for the trajectory instead of zero slope: at first the
number of bound receptors increases without any production of
IFNB1 message, indicating paracrine signaling. Later in the
simulation this leads to IFNB1 production with numbers increasing
rapidly through the positive feedback loop. Notably, the ratio
between early and late responders is 7:124 in the simulation,
supporting the hypothesis that a small percentage of the
population is responsible for activating the whole culture of cells.
Figure 6D follows the same cell in two simulations, one without
antibodies (solid line), and one with antibodies (dashed line), and
highlights the effect of suppressing paracrine signaling on late
responder cells. In the simulation with no antibodies the cell
exhibits a clear late responder trajectory. However, when the
paracrine signaling is suppressed the trajectory becomes similar to
that of an early responder, where IFNB1 induction starts before
any receptors are bound. This induction occurs late in the
simulation and results in lower steady state values, due to partial
blocking of the feedback loop.
Thus far we have shown that the proposed mechanism (of a sub
population of early responders efficiently activating the rest of the
cells) is consistent with the experimental results. Cell-to-cell
variations are essential for the process to occur so that interferon-
induced genes will seem to be activated prior to significant interferon
activation. To test this conjecture, we ran the simulation with
decreasing levels of cell-to-cell variability, while maintaining the
same average initial RIG-I concentration, and the same percentage
of early responding cells To this end, the sensitivity of IFNB1
induction to the concentration of RIG-I (parameter c) was increased
(see Supplementary Text S2, Changing the Variance and
Maintaining Early Responder Percentage, for details). Figure 7
Figure 3. Single DC simulations with and without IFN-blocking antibodies. 3A. Time course of the average copy number of IFNB1 (solid line)
and of DDX58 (dashed line) obtained from the simulation with the ABM model. 3B. Scatter plots display IFNB1 (X axis) and DDX58 (Y axis) mRNAs copy
numbers in each single DC as simulated with the ABM model. Simulations without blocking antibodies (upper panel) or with blocking antibodies
(lower panels) are shown at 6 hrs (left) and 11 hrs (right) post infection.
doi:10.1371/journal.pone.0016614.g003
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with initial conditions with 10 times less variability in the initial
DDX58 distribution. As the variance is decreased, the sensitivity of
IFNB1 becomes large enough for small fluctuations in the
concentration of RIG-I to significantly push a cell closer to
activation. As a result, many cells are activated by their internal
levels of RIG-I (which is not significantly different from the average)
and so the average activation of IFNB1 occurs earlier. Figure 7
confirms that decreasing the variability results in similar activation
times for IFNB1 and DDX58, supporting our claim that variability is
essential in order to induce the dynamics seen in the system. We also
note that the simulation with reduced variability results in
significantly higher levels of interferon, which can be harmful. As
such,theearlyresponderdynamicsallowsanefficientresponsetothe
viral infection while maintaining controlled levels of interferon
induction.
Discussion
The general picture that emerges from our experimental and
modeling studies of the early immune response to viral infection
provides a fine grain, mechanistic view of how a sub-population of
early responder cells can facilitate the activation of a positive
feedback loop in the whole population of cells. Two waves of Type
I IFN induction by NDV infection of murine fibroblasts were
previously observed and attributed to a positive feedback loop of
IFNb and IFNa4 inducing IRF7 [13]. Our single cell level study
results are consistent with a positive feedback loop at the
population level [13]. At early time points after viral infection,
only a few infected cells respond to the infection, while all others
remain unaltered. The early responder cells produce and secrete
interferon that – after binding to interferon receptors – induces
DDX58 both in themselves and in neighboring cells. If a
neighboring cell is already infected, the increased amount of
DDX58 will facilitate viral detection and subsequent IFNB1
production. This process of IFNB1 induction is stochastic,
depending on many sources of noise, among which are the time
to signaling component activation and subsequent time to IFNB1
enhanceosome formation. Even if a neighboring cell is not infected
it will be primed through the induction of DDX58 to better resist
subsequent viral infection. The result is that in all cells DDX58 is
increased beyond the control level (Figure 2B) a few hours after
Figure 5. Single cell simulations of early responder DCs. Simulation scatter plots of IFNB1 (X axis) and of DDX58 (Y axis) copy numbers in
individual DCs at 1, 2, 3 and 4 hours post infection. The simulations were performed with 1000 cells in order to show a sufficient number of cells
responding to infection at early time points.
doi:10.1371/journal.pone.0016614.g005
Figure 4. Experimental results in individual DCs with and without blocking antibodies. The scatter plots display IFNB1 (X axis) and DDX58
(Y axis) copy numbers in individual cells, as determined by the hemi-nested single cell qRT-PCR, and normalized to ACTB. 4A. IFNB1 and DDX58
expression in single DCs with no NDV infection and no antibody blockage. 4B. IFNB1 and DDX58 expression in single DCs following NDV infection. In
the same order as in Figure 3B, experiments without blocking antibodies (upper panels) or with blocking antibodies (lower panels) are shown at 6 hrs
(left) and 11 hrs (right) post infection. Note that the dataset for 6 hours was obtained from donor 1, while the datasets for 11 hours and uninfected
control were obtained from donor 2.
doi:10.1371/journal.pone.0016614.g004
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impact of Jak/Stat pathway induction of DDX58 on IFNB1
production is seen at the cell population level as the latter rises
rapidly on average (Figure 1A) with many cells producing a
thousand and more copies (Figures 2,4).
The model time behavior allows one to connect the very early
cellular responses to experimental measurements at 6 and
10 hours that show a large cell-to-cell variability in interferon
induction (Figures 2,4), that is consistent with previous results
[14,15,16]. The fit to these later time data determines model
parameter values, which were then tested by making predictions
and comparing them to experiment when interferon diffusion is
suppressed. The model shows the right qualitative behavior, which
supports the hypothesis that the very early immune response is
carried by a small subset of early responder cells. We have thus
uncovered in the early immune response another instance where
single cell dynamics is different from cell population behavior [17],
as has been shown to occur in various systems such as the Xenopus
oocytes response to progesterone level [18] and PC12 responses to
oxidative stress [19]. In view of the experimental difficulty of
measuring reliably small numbers of mRNA, our methodology
had to rely on a combination of model simulation and
experimental validation, with the model providing the bridge
between the presumed existence of early responder cells and the
later single cell measurements.
One might question some of the simplifying assumptions that
went into our model. Firstly, there is the representation in 2
dimensions of 3 dimensional processes. However, since we impose
in 2 dimensions average experimental cell distance and diffusion
time, we mimic closely in 2 dimensions the temporal 3 dimensional
behavior. Thus a crucial aspect of a realistic situation is preserved,
despite the fact that in 3 dimensions the number of neighboring
cells is larger, which entails that more interferon molecules
impinge on a cell’s surface receptors. The latter situation can
however be compensated for in 2 dimensions by an increase in the
receptor binding probability. Secondly, in terms of intracellular
processes we limit ourselves to those mRNA that are actually
measured, and that compose the DDX58-IFNB1 feedback loop.
Figure 6. Phase space trajectories of individual cells in simulations. Each plot follows a single cell at 10 minute intervals, and plots the
number of bound receptors vs. the number of IFNB1 messages in that cell at that time point. A. An uninfected cell cannot produce IFNB1 message,
and thus exhibits only an increase in the number of bound receptors. B. A late responder cell is characterized by receptors binding before the cell
produces IFNB1 messages, and is thus activated only through paracrine signaling. C. An early responder cell produces considerable amounts of IFNB1
message prior to significant receptor binding, suggesting an autocrine activation. The ratio between early and late responders in the simulation is
7:124. D. A cell that shows a late responder trajectory in the simulation without antibodies (solid line), but changes to a trajectory suggesting
autocrine activation when the simulation includes antibodies (dashed line).
doi:10.1371/journal.pone.0016614.g006
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IFNB1 induction through its contribution to viral detection, IRF7,
which is induced at the same time as RIG-I, is important as well in
enhancing interferon production. We concentrated on RIG-I
because of its participation in the interferon feedback loop,
because DDX58 induction averaged over the cell population
occurs unexpectedly earlier than IFNB1 induction, and because in
the model it appeared reasonable to assume that the distribution of
RIG-I across single cells provides the variability that differentiates
early from late responders. Eliminating our simplifying assump-
tions would impose a huge computational burden for the first
assumption, and force the introduction of additional reactions and
unknown parameters for the second one. We have also performed
simulations at lower DC concentration and checked that, although
the activation of the late-responding cells was somewhat delayed,
the results obtained are qualitatively similar.
In the model, cellular heterogeneity results from a distribution
of constitutive RIG-I across cells coupled to a threshold for viral
detection. We do not know whether this mechanism is actually the
one that distinguishes early responder from late responder cells.
We have verified (Supplementary Figure S3) that the heteroge-
neity is not due to the degree of DC differentiation, but other
sources of cell-to-cell variability can of course exist.
Our investigation illustrates some of the advantages of
integrating experimentation with modeling for immunological
studies. Formal modeling sharpens the development of hypotheses
and the interpretations of data. It allows rapid computational
experiments and leads to predictions to guide subsequent bench
experiments. Obtaining representative single cell measurements in
individual infected human dendritic cells at early time points is
difficult. The experimental intractability of this problem is
sharpened by the inability to detect early responder cells even
with the extremely sensitive assay that we used. We note that this
assay is more accurate than a reporter construct, and is a direct
measurement of promoter activity in individual cells. Direct
measurement of IFNb protein production in single cells would be
ideal for testing our hypotheses. However, detection of protein
level by antibody binding assay would require inhibition of IFNb
secretion, which would alter the DC response to viral infection.
The limited detection sensitivity at early time points is also a
barrier to precisely measuring the single cell level of IFNb.
Interestingly, in the key immune response system we have
studied, the emergent system-wide behavior results from, and
depends on, noise, i.e. the enormous response variability between
cells. The noisiness of this system may have physiological
importance beyond merely resolving an experimental population
level paradox in the DDX58-IFNB1 loop. The high degree of
variation in response and its role in initiating the antiviral feedback
loop could play a role in contributing to effective antiviral
responses in vivo to a wide variety of viral pathogens. The capacity
for a few cells to respond early and their capacity to produce an
interferon signal that primes other cells could be beneficial in
helping mount a response to viruses expressing immune
antagonists. Furthermore, the noisiness of the interferon response,
in which a few cells are activated but most remain silent, may help
in avoiding a cytokine storm while mounting an appropriate
response to infection.
Materials and Methods
Differentiation of DCs
All human research protocols for this work have been approved
by the IRB of the Mount Sinai School of Medicine. The IRB of
the Mount Sinai School specifically waived the need for consent
due to use of discarded samples not traceable to source. Monocyte-
derived conventional DCs were obtained from human blood
donors following a standard protocol [20]. Briefly, human
monocytes from buffy coats were isolated by Ficoll density
gradient centrifugation (Histopaque, Sigma Aldrich) and CD14
+
monocytes were immunomagnetically purified by using a MACS
CD14 isolation kit (Miltenyi Biotech.). CD14
+ monocytes
(0.7610
6 cells/ml) were later differentiated into immature
MDDCs after 5-6 day incubation in DC growth media [RPMI
Medium 1640 (Gibco), 10% fetal calf serum (Hyclone), 2 mM of
L-glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin
(Pen/Strep) (Invitrogen), 500 U/ml hGM-CSF (Preprotech) and
1000 U/ml hIL-4 (Preprotech)] at 37uC.
Virus preparation and viral infection
The recombinant Hitchner B1 strain of Newcastle disease virus
(rNDV/B1) was prepared as previously described [8,14]. Using
our established protocol [14], the titered NDV stock was diluted
40 times in Dulbecco’s Modified Eagle Medium (DMEM) and
added directly into pelleted MDDCs at a multiplicity of infection
(MOI) of 0.5. MOI was measured as previously described by
determining the frequency of cells expressing the NDV L gene
mRNA [14]. After incubation for 30 minutes at 37uC, fresh DC
growth medium was added back to the infected MDDCs
(1610
6cells/ml). Virus free allantoic fluid was added to additional
tubes of cells to serve as a negative control.
Antibody blockage
To block IFN signaling, MDDCs (1610
6 cells/ml) were
pretreated for 30 minutes at 37uC before NDV infection with a
Figure 7. Single DC simulation with high and low cell-to-cell
variation. Time course of the average copy number of IFNB1 per
infected cell (solid line) and of DDX58 (dashed line) obtained from the
simulation with the ABM model. The lines marked by ‘‘Using Fitted
Variance’’ are drawn from a simulation with parameters fitted to the
experimental data, and are identical to the ones shown in Fig. 3A. The
lines marked by ‘‘Using Reduced Variance’’ result from a simulation in
which the variance of the initial DDX58 concentration was reduced 10-
fold. In order to ensure a similar number of early responder cells, the
sensitivity of IFNB1 to RIG-I concentration was increased by more than
30-fold. The reduction in variability leads to results that do not account
for the observed delay in IFN induction relative to DDX58 induction.
Furthermore the highly variable system generates low levels of early
interferon signaling that can initiate antiviral responses without being
prone to later high and potentially toxic levels of interferon secretion.
doi:10.1371/journal.pone.0016614.g007
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I IFNa neutralizing antibodies (PBL Biomedical Laboratories)
(4000 U/mL), polyclonal sheep anti-human type I IFNb neutral-
izing antibodies (PBL Biomedical Laboratories) (4000 U/ml) and
monoclonal mouse anti-human type 1 IFN-a/b receptor chain 2
neutralizing antibodies (Antigenix) (10 mg/ml).
Sorting of single MDDCs
Single MDDCs were directly sorted into 384-well PCR plates as
previously described [14]. Briefly, MDDCs were screened and
sorted by visual light scatter or labeled fluorescence (MoFlo high
speed cell sorter) directly into 384-well bar-coded PCR plates
(Roche LC480), which contained 5 mL cell lysis buffer [4 mM
magnesium acetate (Sigma), 0.05% NP40 (Sigma), 0.8 U/mL
Protector RNAse Inhibitor (Roche Applied Sciences)] in each well.
Sorted MDDCs were immediately placed on dry ice and stored at
–70uC to prevent RNA degradation.
Real time RT-PCR of total RNAs
Cultured human MDDCs (1610
6cells) were divided into two
samples (5610
5cells each). Cells in one sample were infected by
NDV at an MOI of 0.5 and cells in another sample were
uninfected and used as an experimental control. Total RNAs were
isolated from both samples using an RNeasy mini kit (Qiagen)
after 10-hour infection. 100 ng of RNA sample was used as
template for real time RT-PCR to determine the expression levels
of IFNB1 and DDX58. The details of the PCR reactions are
presented in Supplementary Text S1 (Detailed PCR Protocols).
The data were normalized to the housekeeping gene ACTB.
Single cell hemi-nested PCR
Single MDDCs were sorted directly into 384-well bar-coded
PCR plates as previous described [14]. Specifically, a 5 mL aliquot
of a 2x AccuRT master mix solution prepared as described above
was added to each well. In control wells with no cells, 1 mLo f
genomic DNA of varying dilutions (10
3–40 copies/mL) was added
along with the 5 mL aliquot of 2x master mix. Hemi-nested PCR
was performed as described in Supplementary Text S1 (Detailed
PCR Protocols) for the multiplex hemi-nested PCR of IFNB1 and
DDX58. PCR results were analyzed with the Roche Lightcycler
480 where the PCR cross point (Cp) value for each amplification
curve was determined by a secondary derivative calculation. Cp
values were converted to copy numbers using the absolute
quantification method based on Cp values for the genomic DNA
standards. An illustration of the experimental procedure is shown
in Supplementary Figure S4 with validation data in Supplemen-
tary Figures S5,S6. A few PCR dropouts (for both IFNB1 and
DDX58) were observed and excluded from analysis.
Agent based model of RIG-I mediated DC response to
viral infection
Single-cell stochastic behavior is important in many biological
processes, leading to phenotypic variability among genetically
identical organisms and determining cellular fate following viral
infection in bacteria and eukaryotic cells [21,22,23,24,25,26,
27,28,29]. In order to test the hypothesis of early responder cells
we developed an agent based model (ABM) that simulates the
IFNB1-DDX58 positive feedback loop. The simulation emulates a
portion of a medium containing both infected and uninfected
MDDCs. The inter-cellular model we use is two dimensional (2d),
and the medium is represented by a square lattice, where each
lattice square has the size of a single cell (Supplementary Figure
S7). Each cell is simulated as an independent agent, where the
agents interface through the extracellular medium. The graphical
display engine generates an animation by depicting the state of the
simulated area at each simulation step.
Where possible, parameters used in the simulation were based
on experimental results. The experimental basis for parameter
values related to extracellular signaling was summarized previously
[30]. We assume that these same values are applicable to our 2d
lattice model. The measured diffusion rate is of the order of
D~3:10{11m2
sec
, and the diameter of a cell is 30 mm. The diffusion
coefficient and the lattice unit size determine the time step in the
simulation, leading to a time step of 9 seconds (as explained
below). We chose the total lattice size according to the diffusion
distance after 11 hours, which is the latest measurement time.
Since the average displacement of a molecule performing a
random walk or diffusing increases like the square root of time this
leads to a lattice size of 40 by 40 units. According to [30], 6.5% of
the medium’s volume is occupied by the cells, which translates to
an average distance between neighboring cells of about 2.5 times
their diameter. We used this average distance between nearest
neighbors in the 2d simulation, which leads to a population of a
little over 200 cells in the whole lattice, distributed randomly.
Intra-cellular simulation
In order to reflect the variations in response that result from a
small number of reactants within individual cells, the dynamics of
each cell was simulated using a stochastic simulation based on
Gillespie’s algorithm. The simulation follows the number of
transcripts of IFNB1 and of DDX58, the number of RIG-I proteins,
and the number of bound receptors on every cell. The initial RIG-
I level in each cell was chosen from a log-normal distribution so
that a small number of cells had a large amount of RIG-I, while
the majority had a small amount [31]. The parameters for IFNB1
induction were chosen so that only cells with sufficient RIG-I
could be induced. RIG-I concentration in infected cells determines
IFNB1 induction in a Michaelis-Menten like form. Bound cell
surface receptors activate DDX58 transcription according to a
Michaelis-Menten like function.
Stochastic Processes, Rates, and Rate Constants
The modified Gillespie algorithm to stochastically simulate each
cell follows the time dependence of IFNB1 transcripts, DDX58
transcripts, and RIG-I proteins. These molecular species are
denoted as IFN, DDX, and RIG, respectively. The simulation
follows six reactions, as summarized in Figure 8: DDX58 message
transcription, IFNB1 message transcription, RIG-I translation,
DDX58 message degradation, IFNB1 message degradation, and
RIG-I degradation.
The rate constants for IFN and DDX transcription are denoted
by KIFN and KDDX, respectively. The translation rate constant for
RIG is given by KRIG. The degradation rate constants for IFN,
DDX, and RIG are given by dIFN,dDDX, and dRIG, respectively.
The transcription rate DDX58 depends on the number of bound
interferon receptors, denoted by B, in a Michaelis-Menten form
using a Hill coefficient of HDDX~1:5 and a half-induction level
given by 1=b (meaning that when B~b, DDX58 reaches half it
maximal induction). According to experiments, DDX58 is
constitutively expressed in the cells. The ratio between the
maximal induction of DDX58 and the constitutive induction is
given by C~1=50. IFNB1 induction depends on Rig-I concen-
tration in a Michaelis-Menten form with a Hill coefficient
HIFN~3, and a half-induction concentration give by 1=c. All
the degradation processes follow an exponential decay. The
processes and the rates at which they occur are summarized
IFNB1-DDX58 Feedback Loop Cell-to-Cell Variability
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degradation of molecules, respectively):
The values used for the rate constants are based on
experimental results, and were changed to fit the experimental
data. Specifically, in the simulation results shown in the paper the
valuesb~
1
75
, c~
1
7000
, dDDX~
1
104sec
, dIFN~
1
104sec
, and
dRIG~
1
104sec
were used. In order to account for some of the
cell-to-cell variation, the transcription rate constants for each cell
in the simulation were chosen from a Gaussian distribution around
the values KDDX~
1
20sec
, KRIG~
1
20sec
, with standard deviations
of 0.01, and values below 0.01 and above 0.05 were ignored and
re-sampled.
Inter-cellular Diffusion Simulation
The inter-cellular medium is simulated by a Monte-Carlo
simulation on a 2d square lattice. The simulations were performed
in 2D to reduce computational overhead and because, as discussed
below, the conclusions are applicable to the 3D case. The inter-
cellular simulation follows the diffusion of interferon molecules in the
medium, which is described by the diffusion equation. Thus the
average displacement of each molecule from its origin increases as the
square root of time. This result holds for 3d systems, as well as for 2d
ones. The difference between 2D and 3D can be accounted for by a
change in the value of the diffusion coefficient. In order to preserve
the average time for the diffusion to a neighboring cell, we keep the
average distance between neighboring cells equal to the one found in
3d. Besides the distance between nearest neighbors, the interaction
between secreted interferon molecules and a neighboring cell also
depends on the probability of binding to cell-surface receptors, and
the dimensionality of the system. By changing the cell surface binding
probability, we can replace the 3d system by an equivalent 2d system,
in which the interaction of neighboring cells is unchanged. We
recognize that there are differences between the 2D and 3D systems.
For example, in random walks in 2d as compared to 3d, the
probability of a moleculeto return to its origin is higher. Therefore, in
our simulations, the amount of paracrine signaling is underestimated
compared to autocrine signaling. However, this difference is
immaterial for the questions addressed and for the conclusions of
the present study.
The 2d lattice is simulated using periodic boundary conditions,
and its grid size is set to be the diameter of a single cell, denoted L,
which is approximately 30 mm. Cells are distributed inside the
matrix randomly with a density that ensures the correct average
distance to nearest neighbors (as explained above). Each cell has a
probability of 50% of being infected or uninfected, in accordance
with the experimental MOI of 0.5. Uninfected cells do not
transcribe interferon. At each grid point the simulation follows the
amount of interferon molecules, denoted I, and uses the number of
free and bound interferon receptors obtained from each cell,
denoted F, and B, respectively. Grid squares that do not contain a
cell have zero F and B at all times. Receptor binding and
unbinding by IFNb are adapted from work described in reference
[30].
At each time step interferon molecules in lattice squares
containing cells may bind to free surface receptors, while bound
receptors may unbind. The binding rate is given by KON:F:I,
where KON~
1:25
106sec
is the binding rate constant. The unbinding
rate constant was found to be KOFF~
1
103sec
. The rates per
receptor are slow enough so that for the chosen time-step we have
KON:I:Dtvv1 and KOFF:Dtvv1. Therefore we approximate
the binding probability of each free receptor in a time step by
KON:I:Dt, and the unbinding probability for every bound receptor
by KOFF:Dt.
The distribution of molecules in a diffusion-governed system
with initial condition of all the molecules concentrated at the
origin is expressed by a Gaussian function fx ,y,t ðÞ ~
1
4ptD
e
{ x2zy2 ðÞ =4Dt, allowing calculation of the time by which
half the molecules pass a distance of a cell radius, giving
approximately 9 seconds (solving the equation
Ð L=2
{L=2 f(j,g,t)djdg~0:5, with L=30mm). We use this time
interval as the basic time-step in the simulation, during which
each interferon molecule has a probability of 50% to pass to a
neighboring lattice square. As a result, in each simulation step
each interferon molecule in each cell has a probability of 50% of
moving to one of the four neighboring cells. This ensures a
random walk behavior for a small number of molecules, and a
diffusion behavior for large numbers of molecules.
Figure 8. Processes, Descriptions and Rates. The processes, descriptions and rates for each of the six reactions in the stochastic simulations.
doi:10.1371/journal.pone.0016614.g008
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Simulation
The Monte-Carlo simulation and the Gillespie simulation run at
different time-scales and different length scales. The spatial
interaction is explicitly manifested by assigning each cell to a unique
lattice square. In order to account for the different time scales we
must synchronize the constant time step of the Monte-Carlo with the
variable (and often much faster) time step of the Gillespie simulations.
To do this, we allow the Gillespie algorithm of each cell to run for a
number of steps, until the total amount of time of these steps exceeds
the Monte-Carlo time step. The last step is not performed, and the
time is advanced to match the next Monte-Carlo time step. This
procedure ensures the simulation of a real Markovian process when
the external conditions change at pre-determined times.
Another aspect of synchronizing the inter-cellular Monte-Carlo
simulation with the intra-cellular Gillespie simulations involves the
secretion of interferon molecules from each cell. At each Monte-
Carlo step, each cell is queried for the number of IFNB1 messages
in that cell. We assume that the number of new interferon proteins
at each simulation time step is the number of IFNB1 transcripts
multiplied by a factor of M=0.1 (which corresponds to a
translation rate of 1
90sec). We further assume that interferon
secretion is a rapid process and that all the newly synthesized
interferon is secreted at each time step. The number of secreted
interferon molecules is added to the number of interferon
molecules in the lattice square occupied by the cell.
Simulations with Interferon-Blocking Antibodies
Two kinds of antibodies were introduced in the experiments.
One targets the interferon molecules, and the other targets the
interferon cell surface receptors. To include this in the simulation
we added two parameters to the Monte-Carlo simulation of the
inter-cellular medium. First we allowed each interferon molecule
to become inactive by binding to an antibody with a probability of
0.4 at each Monte-Carlo time step. This corresponds to an
effective degradation rate of approximately 1
25sec, and allows the
interferon molecules to form a cloud around the emitting cells, but
hardly any can reach a neighboring cell. The binding rate was
reduced by multiplication of KONby a factor of 0.9. This means
that even the few molecules that are able to reach neighboring cells
have a harder time activating it, and is equivalent to reducing the
number of active receptors by the same factor of 0.9.
Supporting Information
Figure S1 Measurement of NDV L gene, IFNB1, IFNA1, MXA,
and DDX58 transcripts in human MDDCs at 0, 3, 6 and 10 hours
following NDV infection. Total mRNA expression of these genes
was quantified by real-time RT-PCR and induction fold increases
were normalized to the initial value at 0 hrs post infection. A.
IFNB1;B .DDX58; C. NDV L gene; D. MXA;E .IFNA1.
(TIF)
Figure S2 Time course for IFNB1 and DDX58 induction in
MDDCs infected by NDV at different MOI. MDDCs were
infected by NDV at MOI=0.1, 0.5, 1.0, 2.0 and 5.0. Expression
levels were measured at 1, 2, 3, 4, 5, 6 and 10 hours after infection.
The relative induction level was normalized to ACTB and to an
uninfected control. A. IFNB1 (upper panel early times, lower panel
later times) B. DDX58.
(TIF)
Figure S3 Effect of DC heterogeneity in the DC response to
NDV infection. The real-time RT-PCR cross point (Cp) value
indicates the level of IFNB1 in each individual DC (high Cp value
means low expression). 6 hour after NDV infection, single
MDDCs sorted by DC differentiation marker CD14 (0=
CD14+ high, 1=CD14+ low) showed high heterogeneity in both
groups but no significant difference in IFNB1 production between
the two groups (p=0.17).
(TIF)
Figure S4 Schematic illustrating the hemi-nested PCR protocol
used to measure IFNB1 mRNA levels in single DCs. DCs were
directly sorted into 384-well PCR plates prepared with lysis buffer.
Amplification of mRNAs was performed with the two-step hemi-
nested real time RT-PCR. The first step was reverse transcription
reaction followed by 8-cycle amplification. Internal control
oligonucleotides containing mutations (AA/TT substitution and
deletion of the Roche LNA probe binding site) and IFNB1 mRNA
transcripts were both amplified by the primers in this first step
reaction. The PCR products were split into two PCR wells and
further amplified and detected by second real time PCR reactions.
An IFNB1 cDNA-specific forward primer with AA at the 39end
and the IFNB1 cDNA-specific Roche LNA Taqman probe were
added into the second real time PCR reaction to discriminate the
PCR products from internal control oligonucleotides. The final
amplification signal of the second PCR originated only from the
IFNB1 mRNAs.
(TIF)
Figure S5 Validation of the hemi-nested real time PCR method
with serial dilutions of genomic DNA. 5A. Human genomic DNA
was used as the PCR template and serial diluted to 4000 copies,
400copies, 40 copies, 4 copies in each well. The PCR
amplification curves of 4 repeats of 4000 copies and 400 copies,
8 repeats of 40 copies, 10 repeats of 4 copies and negative controls
are shown. A standard curve of qcPCR with diluted genomic
DNA is presented as an inset. The linear fitting equation and r
2
shown in the inset were given by KaleidaGraph. 5B. Real-time
PCR amplification curve of human genomic DNA standard using
IFNB1 control oligonucleotide specific primer. This oligonucleo-
tide specific primer has been designed to anneal only with PCR
amplicons originated from the IFNB1 control oligonucleotide
(details see Materials and Methods section). Our data showed
a very tight distribution at the different concentrations of the
genomic standard (10
3–fold range).
(TIF)
Figure S6 Validation of multiplexed hemi-nested real time PCR
detection with total RNA dilutions. Total RNAs were extracted
from MDDCs and 10-fold serially diluted until the final
concentration reached copy numbers similar to the low copy
genomic DNA standards depicted in Supplementary Figure S5A.
In order of RNA copy number from high to low, the results are for
results from 6 repeats, 6 repeats, 12 repeats and 18 repeats of PCR
reactions. 6A. PCR amplification curve of IFNB1 for total RNA
dilutions. 6B. PCR amplification curve of DDX58 for total RNA
dilutions. The final dilution did not show DDX58 amplification
due to lower expression of DDX58 than IFNB1 (less than 1 copy/
cell).
(TIF)
Figure S7 Two dimensional agent-based model (ABM). The
extracellular model is two dimensional, and the medium is
represented by a square lattice, where each lattice square has the
size of a single cell. Each cell is simulated as an independent agent,
where the agents interface through the extracellular medium.
(TIF)
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